Long School of Medicine
UT Health San Antonio, with its clinical partner University Health System, are among the first study sites in the nation to begin the third phase of the COVID-19 clinical trial involving remdesivir.
Dr. Fred Campbell, General and Hospital Medicine, said directing coughs and sneezes directly into your elbow is the best way to minimize the spread of droplets that might have the coronavirus. Read and listen to the interview.
Dr. Holly Day, Hospital & General Medicine, spoke to News 4 audiences regarding COVID patients who also may be fighting COVID pneumonia, one of the most common resulting issues that can be unusually severe and lead to chronic lung disease. Read and watch the story.
KSAT 12: COVID-19 numbers trending in the right direction, but more work still needed, infectious disease specialist saysAugust 7, 2020
Dr. Jan Patterson, Infectious Diseases, discussed several vaccine trials in San Antonio, including UT Health San Antonio becoming an approved site for the Novavax vaccine. She also mentioned that a new stage of the remdesivir trial has begun with patients receiving remdesivir plus an immunomodulator called Interferon Beta 1 Alpha. Read and watch the story.
The Hill: Latinos disproportionately affected by coronavirus, sheds a light onto existing inequitiesAugust 7, 2020
Dr. Amelie Ramirez, Salud America/Institute for Health Promotion Research, comments to The Hill in a feature on Latinos being disproportionately affected by coronavirus. Read the story.
This BBC story mentions a research review on children and COVID-19 compiled at UT Health San Antonio and led by Dr. Alvaro Moreira, Pediatrics-Neonatology. Read the story.